Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Direct identification of clinical pathogens from liquid culture media by MALDI-TOF MS analysis

  • Oviaño, M.
  • Rodríguez-Sánchez, B.
  • Gómara, M.
  • Alcalá, L.
  • Zvezdanova, E.
  • Ruíz, A.
  • Velasco, D.
  • Gude, M.J.
  • Bouza, E.
  • Bou, G.
Objectives: We propose using MALDI-TOF MS as a tool for identifying microorganisms directly from liquid cultures after enrichment of the clinical sample in the media, to obtain a rapid microbiological diagnosis and an adequate administration of the antibiotic therapy in a clinical setting. Methods: To evaluate this approach, a series of quality control isolates were grown in thioglycollate (TG) broth and brain heart infusion (BHI) broth and extracted under four different protocols before finally being identified by MALDI-TOF MS. After establishing the best extraction protocol, we validated the method in a total of 300 liquid cultures (150 in TG broth and 150 in BHI broth) of different types of clinical samples obtained from two tertiary Spanish hospitals. Results: The initial evaluation showed that the extraction protocol including a 5 minute sonication step yielded 100% valid identifications, with an average score value of 2.305. In the clinical validation of the procedure, 98% of the microorganisms identified from the TG broth were correctly identified relative to 97% of those identified from the BHI broth. In 24% of the samples analysed, growth by direct sowing was only successful in the liquid medium, and no growth was observed in the direct solid agar cultures. Conclusions: Use of MALDI-TOF MS plus the sonication-based extraction method enabled direct and accurate identification of microorganisms in liquid culture media in 15 minutes, in contrast to the 24 hours of subculture required for conventional identification, allowing the administration of a targeted antimicrobial therapy.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

  • Pérez-Nadales, E.
  • Alastruey-Izquierdo, A.
  • Linares-Sicilia, M.J.
  • Soto-Debrán, J.C.
  • Abdala, E.
  • García-Rodríguez, J.
  • Montejo, M.
  • Muñoz, P.
  • Lletí, M.S.
  • Rezusta, A.
  • de Pipaón, M.R.P.
  • Yáñez, L.
  • Merino, E.
  • Campos-Herrero, M.I.
  • Costa-Mateo, J.M.
  • Fortún, J.
  • García-Lozano, T.
  • Garcia-Vidal, C.
  • Fernández-Ruiz, M.
  • Sánchez-Reus, F.
  • Castro-Méndez, C.
  • Guerrero-Lozano, I.
  • Soler-Palacín, P.
  • Aguado, J.M.
  • Martínez-Martínez, L.
  • Torre-Cisneros, J.
  • Nucci, M.
In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate. For CME questions, see page 339.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

  • Beltrán-Pavez, C.
  • Gutiérrez-López, M.
  • Rubio-Garrido, M.
  • Valadés-Alcaraz, A.
  • Prieto, L.
  • Ramos, J.T.
  • Jiménez De Ory, S.
  • Navarro, M.
  • Díez-Romero, C.
  • Pulido, F.
  • Valencia, E.
  • Holguín, Á.
  • Mellado, M.J.
  • Escosa, L.
  • García Hortelano, M.
  • Sainz, T.
  • González-Tomé, M.I.
  • Rojo, P.
  • Blázquez, D.
  • Prieto-Tato, L.
  • Epalza, C.
  • Ramos, J.T.
  • Guillén, S.
  • Navarro, M.L.
  • Saavedra, J.
  • Santos, M.
  • Santiago, B.
  • Aguilera-Alonso, D.
  • Jiménez De Ory, S.
  • Carrasco, I.
  • Roa, M.Á.
  • Penín, M.
  • Martínez, J.
  • Badillo, K.
  • Oñate, E.
  • Pocheville, I.
  • Garrote, E.
  • Colino, E.
  • Gómez Sirvent, J.
  • Garzón, M.
  • Román, V.
  • Angulo, R.
  • Neth, O.
  • Falcón, L.
  • Terol, P.
  • Santos, J.L.
  • Moreno, D.
  • Lendínez, F.
  • Peromingo, E.
  • Uberos, J.
  • Ruiz, B.
  • Grande, A.
  • Romero, F.J.
  • Pérez, C.
  • Lillo, M.
  • Losada, B.
  • Herranz, M.
  • Bustillo, M.
  • Collado, P.
  • Couceiro, J.A.
  • Vila, L.
  • Calviño, C.
  • Piqueras, A.I.
  • Oltra, M.
  • Gavilán, C.
  • Montesinos, E.
  • Dapena, M.
  • Álvarez, C.
  • Jiménez, B.
  • Andrés, A.G.
  • Marugán, V.
  • Ochoa, C.
  • Alfayate, S.
  • Menasalvas, A.I.
  • Ruiz Del Prado, Y.
  • Soler-Palacín, P.
  • Frick, M.A.
  • Mur, A.
  • López, N.
  • Méndez, M.
  • Mayol, L.
  • Vallmanya, T.
  • Calavia, O.
  • García, L.
  • Coll, M.T.
  • Pineda, V.
  • Rius, N.
  • Dueñas, J.
  • Fortuny, C.
  • Noguera-Julián, A.
  • Bernardino, I.
  • Montes, M.L.
  • Valencia, E.
  • Rubio, R.
  • Pulido, F.
  • Bisbal, O.
  • Gaspar Alonso, G.
  • Berenguer, J.
  • Díez, C.
  • Aldamiz, T.
  • Montilla, P.
  • Bermúdez, E.
  • Valerio, M.
  • Sanz, J.
  • Arponen, S.
  • Gimeno, A.
  • Cervero, M.
  • Torres, R.
  • Moreno, S.
  • Pérez, M.ªJ.
  • Ryan, P.
  • Troya, J.
  • Sanz, J.
  • Losa, J.
  • Gómez, R.
  • Iribarren, J.A.
  • Rodríguez, F.
  • Pascual, L.
  • Aramburu, M.J.
  • Goikoetxea, A.J.
  • Aguirrebengoa, L.
  • Muñoz, J.
  • Ibarra, S.
  • Hernández, M.
  • Gómez Sirvent, J.L.
  • Rodríguez, J.
  • Cárdenes, M.Á.
  • López-Cortés, L.F.
  • Roca, C.
  • Llaves, S.
  • Ríos, M.J.
  • Rodríguez, J.
  • Palomo, V.
  • Pasquau, J.
  • García, C.
  • Hernández, J.
  • Martínez, C.
  • Rivero, A.
  • Camacho, Á.
  • Merino, D.
  • Martínez, E.
  • Mateos, F.
  • Blanch, J.J.
  • Torralba, M.
  • Arazo, P.
  • Samperiz, G.
  • Crusells, M.J.
  • San Joaquín, I.
  • Miralles, C.
  • Ocampo, A.
  • Pousada, G.
  • Mena, Á.
  • Montero, M.
  • Salavert, M.
  • Cuéllar, S.
  • Galindo, M.J.
  • Ferrando, R.
  • Portilla, J.
  • Portilla, I.
  • Gutiérrez, F.
  • Masiá, M.
  • Robledano, C.
  • Adsuar, A.
  • Hinojosa, C.
  • Bachiller, P.
  • Abadía, J.
  • Mostaza, J.L.
  • Pérez, R.
  • Galera, C.
  • Albendín, H.
  • Pérez, A.
  • Blanco, J.R.
  • Burgos, J.
  • Torres, B.
  • Lazzari, E.
The aim of this transversal study was to describe the virological and immunological features of HIV-infected youths transferred from pediatric to adult care units since 1997 vs. the non-transferred patients from the Madrid Cohort of HIV-infected children and adolescents in Spain. We included 106 non-transferred and 184 transferred patients under clinical follow-up in 17 public hospitals in Madrid by the end of December 2017. Virological and immunological outcomes were compared in transferred vs. non-transferred patients. ART drug resistance mutations and HIV-variants were analyzed in all subjects with available resistance pol genotypes and/or genotypic resistance profiles. Among the study cohort, 133 (72.3%) of 184 transferred and 75 (70.7%) of 106 non-transferred patients had available resistance genotypes. Most (88.9%) of transferred had ART experience at sampling. A third (33.3%) had had a triple-class experience. Acquired drug resistance (ADR) prevalence was significantly higher in pretreated transferred than non-transferred patients (71.8% vs. 44%; p = 0.0009), mainly to NRTI (72.8% vs. 31.1%; p < 0.0001) and PI (29.1% vs. 12%; p = 0.0262). HIV-1 non-B variants were less frequent in transferred vs. non-transferred (6.9% vs. 32%; p < 0.0001). In conclusion, the frequent resistant genotypes found in transferred youths justifies the reinforcement of HIV resistance monitoring after the transition to avoid future therapeutic failures.